Edaravone Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Edaravone Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report Code: KNJ585301 | No. of Pages: 103 | Category: Pharmaceuticals and Healthcare
Publisher: 99Strategy | Date of Publish: Jan-2021
Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Edaravone market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Edaravone market segmented into
    Oral
    Injection

Based on the end-use, the global Edaravone market classified into
    Hospital
    Clinic
    Others

Based on geography, the global Edaravone market segmented into
    North America [U.S., Canada, Mexico]
    Europe [Germany, UK, France, Italy, Rest of Europe]
    Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
    South America [Brazil, Argentina, Rest of Latin America]
    Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
    Mitsubishi Tanabe Pharma
    Simcere
    Taj Pharmaceuticals Ltd.
    Sun Pharmaceutical Industries Ltd.
    Unichem Laboratories Ltd
    UCB India Ltd
    Piramal Healthcare
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL EDARAVONE INDUSTRY
    2.1 Summary about Edaravone Industry
    2.2 Edaravone Market Trends
        2.2.1 Edaravone Production & Consumption Trends
        2.2.2 Edaravone Demand Structure Trends
    2.3 Edaravone Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Oral
        4.2.2 Injection
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Hospital
        4.3.2 Clinic
        4.3.3 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Oral
        5.2.2 Injection
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Hospital
        5.3.2 Clinic
        5.3.3 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Oral
        6.2.2 Injection
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Hospital
        6.3.2 Clinic
        6.3.3 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Oral
        7.2.2 Injection
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Hospital
        7.3.2 Clinic
        7.3.3 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Oral
        8.2.2 Injection
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Hospital
        8.3.2 Clinic
        8.3.3 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Oral
        9.2.2 Injection
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Hospital
        9.3.2 Clinic
        9.3.3 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Mitsubishi Tanabe Pharma
        10.1.2 Simcere
        10.1.3 Taj Pharmaceuticals Ltd.
        10.1.4 Sun Pharmaceutical Industries Ltd.
        10.1.5 Unichem Laboratories Ltd
        10.1.6 UCB India Ltd
        10.1.7 Piramal Healthcare
    10.2  Edaravone Sales Date of Major Players (2017-2020e)
        10.2.1 Mitsubishi Tanabe Pharma
        10.2.2 Simcere
        10.2.3 Taj Pharmaceuticals Ltd.
        10.2.4 Sun Pharmaceutical Industries Ltd.
        10.2.5 Unichem Laboratories Ltd
        10.2.6 UCB India Ltd
        10.2.7 Piramal Healthcare
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com